Literature DB >> 19818633

Catalytic and non-catalytic functions of human IIA phospholipase A2.

Charles N Birts1, C Howard Barton, David C Wilton.   

Abstract

Group IIA phospholipase A2 (PLA2) is a low-molecular-mass secreted PLA2 enzyme that has been identified as an acute phase protein with a role in the inflammatory response to infection and trauma. The protein is possibly unique in being highly cationic and having a global distribution of surface arginine and lysine residues. This structure supports two functions of the protein. (1) An anti-bacterial role where the enzyme is targeted to the anionic cell membrane of Gram-positive bacteria and phospholipid hydrolysis assists in bacterial killing. (2) A proposed non-catalytic role in which the protein forms supramolecular aggregates with anionic phospholipid vesicles or debris. These aggregates are then internalized via interactions with cell surface heparin sulphate proteoglycans and macropinocytosis for disposal by macrophages. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19818633     DOI: 10.1016/j.tibs.2009.08.003

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  23 in total

1.  Relationship between membrane permeability and specificity of human secretory phospholipase A(2) isoforms during cell death.

Authors:  Jennifer Nelson; Elizabeth Gibbons; Katalyn R Pickett; Michael Streeter; Ashley O Warcup; Celestine H-Y Yeung; Allan M Judd; John D Bell
Journal:  Biochim Biophys Acta       Date:  2011-04-12

2.  sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model.

Authors:  Yi Wei; Seth P Epstein; Shima Fukuoka; Neil P Birmingham; Xiu-Min Li; Penny A Asbell
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

3.  Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins αvβ3, α4β1, and α5β1.

Authors:  Masaaki Fujita; Kan Zhu; Chitose K Fujita; Min Zhao; Kit S Lam; Mark J Kurth; Yoko K Takada; Yoshikazu Takada
Journal:  J Biol Chem       Date:  2014-11-14       Impact factor: 5.157

4.  Antimalarial Activity of Human Group IIA Secreted Phospholipase A2 in Relation to Enzymatic Hydrolysis of Oxidized Lipoproteins.

Authors:  Mélanie Dacheux; Véronique Sinou; Christine Payré; Louise Jeammet; Daniel Parzy; Philippe Grellier; Christiane Deregnaucourt; Gérard Lambeau
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

Review 5.  Molecular determinants of bacterial sensitivity and resistance to mammalian Group IIA phospholipase A2.

Authors:  Jerrold P Weiss
Journal:  Biochim Biophys Acta       Date:  2015-06-14

6.  Interleukin-22-Induced Antimicrobial Phospholipase A2 Group IIA Mediates Protective Innate Immunity of Nonhematopoietic Cells against Listeria monocytogenes.

Authors:  Yamato Okita; Takeru Shiono; Ayano Yahagi; Satoru Hamada; Masayuki Umemura; Goro Matsuzaki
Journal:  Infect Immun       Date:  2015-12-07       Impact factor: 3.441

7.  Plasma levels of phospholipase A2-IIA in patients with different types of malignancies: prognosis and association with inflammatory and coagulation biomarkers.

Authors:  Mario Menschikowski; Albert Hagelgans; Ulrich Schuler; Susanne Froeschke; Andrea Rosner; Gabriele Siegert
Journal:  Pathol Oncol Res       Date:  2013-06-01       Impact factor: 3.201

8.  Obese rats supplemented with bitter melon display marked shifts in the expression of genes controlling inflammatory response and lipid metabolism by RNA-Seq analysis of colonic mucosa.

Authors:  Juan Bai; Ying Zhu; Ying Dong
Journal:  Genes Genomics       Date:  2018-02-20       Impact factor: 1.839

9.  The phospholipid-repair system LplT/Aas in Gram-negative bacteria protects the bacterial membrane envelope from host phospholipase A2 attack.

Authors:  Yibin Lin; Mikhail Bogdanov; Shuo Lu; Ziqiang Guan; William Margolin; Jerrold Weiss; Lei Zheng
Journal:  J Biol Chem       Date:  2018-01-18       Impact factor: 5.157

10.  53 years old is a reasonable cut-off value to define young and old patients in clear cell renal cell carcinoma: a study based on TCGA and SEER database.

Authors:  Fucai Tang; Zechao Lu; Chengwu He; Hanbin Zhang; Weijia Wu; Zhaohui He
Journal:  BMC Cancer       Date:  2021-05-29       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.